Ticker > Company >

Krebs Biochem.&Inds share price

Krebs Biochemicals & Industries Ltd.

NSE: KREBSBIO BSE: 524518 SECTOR: Pharmaceuticals & Drugs  18k   20   4

80.55
-2.17 (-2.62%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 86.8

Today's Low

₹ 80.55

52 Week High

₹ 121.5

52 Week Low

₹ 60

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

173.67 Cr.

Enterprise Value

367.21 Cr.

No. of Shares

2.16 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -60.36

CASH

0.14 Cr.

DEBT

193.68 Cr.

Promoter Holding

72.74 %

EPS (TTM)

₹  -10.09

Sales Growth

-3.29%

ROE

0 %

ROCE

-18.99%

Profit Growth

20.1 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3.29%
3 Year-2.08%
5 Year1.09%

Profit Growth

1 Year18.94%
3 Year9.12%
5 Year0.26%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year-18.99%
3 Year-34.99%
5 Year-40.44%

Debt/Equity

-1.6246

Price to Cash Flow

75.38

Interest Cover Ratio

-3.207

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 72.74 0.00
Jun 2024 72.74 0.00
Mar 2024 72.74 0.00
Dec 2023 72.74 0.00
Sep 2023 72.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -861.4189 days.
  • The company has a high promoter holding of 72.74%.

 Limitations

  • The company has shown a poor profit growth of 9.26015653462675% for the Past 3 years.
  • The company has shown a poor revenue growth of -2.07817368227831% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of -34.9883110975492% over the past 3 years
  • The company has a low EBITDA margin of -38.5552952855938% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 14.89 12.98 11.97 12.89 12.86
Total Expenditure 15.79 15.07 15.09 15.09 15.57
Operating Profit -0.9 -2.09 -3.11 -2.2 -2.71
Other Income 0.17 0.03 0.21 0.03 0.09
Interest 1.13 1.19 1.27 1.32 1.43
Depreciation 1.71 1.73 1.67 1.69 1.71
Exceptional Items 0 0 0 0 0
Profit Before Tax -3.57 -4.98 -5.85 -5.17 -5.76
Tax 0 0 0 0 0
Profit After Tax -3.57 -4.98 -5.85 -5.17 -5.76
Adjusted EPS (Rs) -1.66 -2.31 -2.71 -2.4 -2.67

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 33.41 53.7 59.7 52.13 50.42
Total Expenditure 51.97 71.28 93.7 67.91 59.15
Operating Profit -18.56 -17.58 -33.99 -15.78 -8.72
Other Income 0.37 0.62 1.16 0.62 0.45
Interest 6 6.28 5.39 2.97 4.69
Depreciation 4.68 5.12 6.3 6.56 6.77
Exceptional Items 0 0 0 0 0
Profit Before Tax -28.87 -28.36 -44.53 -24.69 -19.73
Tax 0 0 0 0 0
Net Profit -28.87 -28.19 -44.87 -24.37 -19.75
Adjusted EPS (Rs.) -16.04 -14.45 -20.65 -11.45 -9.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 18 19.62 21.56 21.56 21.56
Total Reserves -43 -62.35 -96.65 -121.02 -140.78
Borrowings 65.51 100.55 132.93 173.25 183.5
Other N/C liabilities 50.16 53.21 53.9 52.09 52.06
Current liabilities 43.13 48.19 78.06 49.1 61.83
Total Liabilities 133.8 159.22 189.81 174.98 178.17
Assets
Net Block 105.29 117.93 138.71 147.31 149.96
Capital WIP 2.35 10.09 6.53 2.24 0.16
Intangible WIP 1.85 1.85 1.85 1.85 1.85
Investments 0 0 0 0 0
Loans & Advances 5.24 7.71 7.23 7.52 8.77
Other N/C Assets 0.21 0.23 0 0 0
Current Assets 18.86 21.42 35.49 16.06 17.44
Total Assets 133.8 159.22 189.81 174.98 178.17
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -28.87 -28.36 -44.53 -24.69 -19.73
Adjustment 8.95 11.68 11.41 9.82 11.88
Changes in Assets & Liabilities -15.58 2.11 15.9 -9.84 10.15
Tax Paid 0 0 0 0 0
Operating Cash Flow -35.5 -14.57 -17.22 -24.71 2.3
Investing Cash Flow -10.22 -22.55 -22.9 -12.65 -7.82
Financing Cash Flow 28.58 37.66 39.51 37.34 5.56
Net Cash Flow -17.14 0.54 -0.61 -0.01 0.05

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 72.74 72.74 72.74 72.74 72.74
aditya ravi 0.05 0.05 0.05 0.05 0.05
ajay ravi 0.52 0.52 0.52 0.52 0.52
avinash ravi 9.93 9.93 9.93 9.93 9.93
dr r t ravi 0.11 0.11 0.11 0.11 0.11
hemalatha ravi 12.48 12.48 12.48 12.48 12.48
ipca laboratories limited... 49.65 49.65 49.65 49.65 49.65
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 27.26 27.26 27.26 27.26 27.26
sun pharmaceutical indust... 4.81 4.81 4.81 4.81 4.81

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Krebs Biochem.&Inds - Quaterly Results 11 Nov, 1:39 PM Krebs Biochem.&Inds - Quaterly Results 11 Nov, 1:39 PM Krebs Biochem.&Inds - Quaterly Results 11 Nov, 1:39 PM Krebs Biochemicals & Industries informs about closure of trading window 23 Sep, 12:26 PM Krebs Biochemicals & Industries informs about newspaper publication 4 Sep, 12:47 PM Krebs Biochemicals & Industries informs about press release 30 Aug, 12:16 PM Krebs Biochem.&Inds - Quaterly Results 7 Aug, 1:29 PM Krebs Biochem.&Inds - Quaterly Results 7 Aug, 1:29 PM Krebs Biochem.&Inds - Quaterly Results 7 Aug, 1:29 PM Krebs Biochemicals and Industries informs about closure of trading window 21 Jun, 12:52 PM Krebs Biochem.&Inds - Quaterly Results 21 May, 3:50 PM Krebs Biochem.&Inds - Quaterly Results 21 May, 3:50 PM Krebs Biochem.&Inds - Quaterly Results 21 May, 3:50 PM Krebs Biochemicals & Industries informs about board meeting 8 May, 4:57 PM Krebs Biochem.&Inds - Quaterly Results 12 Feb, 1:38 PM Krebs Biochem.&Inds - Quaterly Results 12 Feb, 1:38 PM Krebs Biochem.&Inds - Quaterly Results 12 Feb, 1:38 PM Krebs Biochemicals & Industries informs about compliances-certificate 9 Jan, 12:44 PM Krebs Biochemicals & Industries informs about loss of share certificate 8 Sep, 1:00 PM Krebs Biochemicals and Industries informs about loss of share certificates 31 Aug, 12:29 PM Krebs Biochem.&Inds - Quaterly Results 9 Aug, 4:17 PM Krebs Biochem.&Inds - Quaterly Results 9 Aug, 4:17 PM Krebs Biochem.&Inds - Quaterly Results 9 Aug, 4:17 PM Krebs Biochem.&Inds - Quaterly Results 24 May, 3:59 PM Krebs Biochem.&Inds - Quaterly Results 24 May, 3:59 PM Krebs Biochem.&Inds - Quaterly Results 24 May, 3:59 PM Krebs Biochemicals and Industries informs about result of postal ballot 18 Mar, 10:15 AM Krebs Biochemicals & Industries informs about loss of share certificate 27 Feb, 2:38 PM Krebs Biochem.&Inds - Quaterly Results 3 Feb, 3:38 PM Krebs Biochem.&Inds - Quaterly Results 3 Feb, 3:38 PM Krebs Biochem.&Inds - Quaterly Results 3 Feb, 3:38 PM Krebs Biochem.&Inds - Quaterly Results 10 Nov, 4:14 PM Krebs Biochem.&Inds - Quaterly Results 10 Nov, 4:14 PM KREBS Biochemicals & Industries informs about compliances-certificate 11 Oct, 5:01 PM Krebs Biochemicals and Industries informs about newspaper advertisement 9 Sep, 1:06 PM Krebs Biochem.&Inds - Quaterly Results 1 Aug, 4:15 PM Krebs Biochem.&Inds - Quaterly Results 1 Aug, 4:15 PM Krebs Biochem.&Inds - Quaterly Results 1 Aug, 4:15 PM Krebs Biochem.&Inds - Quaterly Results 23 May, 3:04 PM Krebs Biochem.&Inds - Quaterly Results 23 May, 3:04 PM Krebs Biochem.&Inds - Quaterly Results 23 May, 3:04 PM Krebs Biochemicals & Industries informs about board meeting 5 Feb, 12:32 PM Krebs Biochemicals & Industries informs about compliances-certificate 17 Jan, 5:34 PM Krebs Biochemicals & Industries informs about outcome of board meeting 23 Oct, 11:51 AM Krebs Biochemicals & Industries informs about 29th AGM 2 Sep, 12:37 PM Krebs Biochemicals & Industries informs about board meeting 23 Jul, 10:50 AM Krebs Biochemicals & Industries informs about closure of trading window 27 Mar, 11:01 AM Krebs Biochemicals & Industries informs about newspaper publication 31 Oct, 10:47 AM Krebs Biochemicals & Industries submits scrutinizer’s report 28 Sep, 1:39 PM Krebs Biochemicals & Industries informs about newspaper publication 3 Sep, 3:21 PM

Krebs Biochem.&Inds Stock Price Analysis and Quick Research Report. Is Krebs Biochem.&Inds an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Krebs Biochem.&Inds and its performance over the period of time. Krebs Biochem.&Inds stock price today is Rs 82.3.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Krebs Biochem.&Inds cash from the operating activity was Rs 2.304 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Krebs Biochem.&Inds has a Debt to Equity ratio of -1.6246 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Krebs Biochem.&Inds , the EPS growth was 20.1016 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Krebs Biochem.&Inds has OPM of -17.3021429350575 % which is a bad sign for profitability.
     
  • ROE: Krebs Biochem.&Inds have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Krebs Biochem.&Inds is Rs 82.3. One can use valuation calculators of ticker to know if Krebs Biochem.&Inds share price is undervalued or overvalued.
Last Updated on:
Brief about Krebs Biochem.&Inds
X